The research progress on multi-omics analysis biomarkers of benign prostatic hyperplasia

Abstract

Benign prostatic hyperplasia (BPH) is one of the most common benign diseases among the ageing male population with increasing prevalence, which can cause lower urinary tract symptoms and seriously affect the quality of life of patients. However, currently commonly used diagnostic methods (IPSS, rectal finger imaging, etc.) are difficult to detect to differentiate benign/malignant BPH, so biomarkers are relatively ideal for screening BPH and developing relevant targeted therapeutic drugs. This article reviews the research progress of multi-omics analysis related biomarkers in benign prostatic hyperplasia, including genetic, protein, metabolic, and microbial biological biomarkers, intending to provide direction and basis for early diagnosis of benign prostatic hyperplasia.

Keywords

• benign prostatic hyperplasia
• biomarkers
• multi-omics analysis
• aging